| Literature DB >> 33723658 |
Hafis Muhammed1, Avinash Jain1,2, Mohammad Irfan3, Sheba Charles4, Preksha Dwivedi5, Pallavi Pimpale Chavan6, Raju Khubchandani6, Amit Sharma7, Sanat Phatak8, Anuj N Shukla9, Ripal Shah10, N Subramanian11, Sapan C Pandya12, Yogesh Preet Singh13, K G Chengappa14, Molly Thabah14, Liza Rajasekhar3, Vineeta Shobha4, V S Negi14, Varun Dhir5, Aman Sharma5, Ramnath Misra1, Amita Aggarwal15.
Abstract
Acute pancreatitis (AP) is a rare but life threatening manifestation of Systemic Lupus Erythematosus (SLE). The current study aims to study the clinical characteristics, severity, mortality, and outcome of SLE-related AP in Indian population. We retrospectively reviewed medical records of patients with SLE who had AP in the past. Data from 13 rheumatology centers across India were compiled. All patients satisfied SLICC criteria for SLE and ATLANTA criteria for AP. AP was classified in to mild, moderate and severe using revised Atlanta classification. Patients with known risk factors like gall stone and alcohol were excluded.Sixty-six patients (six, children) were studied. Majority of patients were females (82%). The median age of presentation was 24 (11-63) years and most patients (57.5%) presented within first year of diagnosis of lupus. AP occurred mostly in the setting of active lupus (89%). Active nephritis was seen in 39% while a fourth had CNS disease. Patients with severe AP had lower C3. Ascites and sepsis were most common local and systemic complications, respectively. Mortality was 17%. Hypocalcemia, presence of sepsis and shock predicted mortality. In the multivariate analysis, only presence of shock remained as independent predictor of death (OR 63.0, 95% CI: 5.2-760.3). Pancreatitis is an early manifestation of SLE and is associated with active disease. Significant mortality is seen particularly with severe pancreatitis.Entities:
Keywords: Acute pancreatitis; Gastrointestinal; Systemic lupus erythematosus
Mesh:
Year: 2021 PMID: 33723658 DOI: 10.1007/s00296-021-04834-2
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 3.580